FIG. 4.
The fluorescence intensity of TLR3 staining is decreased on average by 55 or 43% in CD samples compared to healthy controls or UC patients, respectively. Average automatic exposure times of representative samples (n = 7 per disease subgroup) were plotted as an indirect measurement of the fluorescence intensity of TLR3. t test (two tailed, heteroscedastic) results show the following: ∗, CD/Normal, P < 0.01; #, CD/UC, P < 0.03; +, UC/Normal, P > 0.7.